Esperion Therapeutics
ESPR
#7268
Rank
A$0.70 B
Marketcap
A$2.75
Share price
-0.25%
Change (1 day)
87.92%
Change (1 year)

EPS for Esperion Therapeutics (ESPR)

EPS in 2025 (TTM): A-$0.79

According to Esperion Therapeutics's latest financial reports the company's current EPS (TTM) is A-$0.70. In 2024 the company made an earnings per share (EPS) of A-$0.32 an increase over its 2023 EPS that were of A-$2.96.

EPS history for Esperion Therapeutics from 2014 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A-$0.79144.49%
2024A-$0.32-89.15%
2023A-$2.96-40.28%
2022A-$4.96-62.87%
2021A-$13.3680.38%
2020A-$7.4150.14%
2019A-$4.93-53.18%
2018A-$10.547.41%
2017A-$9.81110.81%
2016A-$4.6547.35%
2015A-$3.160.89%
2014A-$3.13

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
A$1.90-372.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
A$60.25-8,724.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
A-$8.16 1,068.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
A-$0.27-62.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
A-$0.15-78.00%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$2.54-464.00%๐Ÿ‡บ๐Ÿ‡ธ USA